You can find the services we offer at a distance via Zoom, Teams, and other internet-based methods on our remote services page.
Evening class instruction is available by request. To see if the RCC Library is closed on school holidays and semester breaks, please consult the Library Calendar.
857-701-1380
or via text at 857-877-2255
library1@rcc.mass.edu
1234 Columbus Avenue
Building 3, Room 211
Boston, MA 02120
Full length and segment videos from:
From spinal cord injuries to autism, our own cells could shape medicine’s next frontier. Dr. Gupta explores the experimental yet encouraging world of stem cells.
Ending Disease is a documentary series that follows patients and their doctors in the first generation of FDA-approved clinical trials for stem cell, CAR-T cell, and antibody therapies. Granted unprecedented access to groundbreaking trials taking place at top research facilities in the United States, our crew filmed through the duration of ten clinical trials that used regenerative medicine to treat brain cancer, breast cancer, leukemia, lymphoma, HIV, spinal cord injury, eye disease, and SCID. Over the course of four episodes, the patients put their hope and their faith in the trials, and we witness as their illnesses are profoundly transformed by pioneering treatments.
Today people in need of bone replacement -- whether because of disease, defect or injury -- can turn to synthetic replacements or they can have another bone in their body cut down so as to supply material for the missing bone. In either case the procedure is extremely painful and not without risk of failure. EpiBone is attempting to disrupt this process by growing human bone from stem cells. (Video by: Brandon Lisy, Justin Beach) (Music by Andy Clausen)
Molecular biology allows scientists and engineers to manipulate the recipes written in our genes. Spotlight some of the developments drawing on these techniques, including cloning, reprogramming cells, harnessing stem cells, and initiatives in "synthetic" biology, a new field that lets researchers create genomes that have never before existed, essentially fashioning entirely new life forms.
In 2011, Lisa Hepner and her husband Guy Mossman heard about a radical stem cell treatment for diabetes, a disease that, shockingly, kills more than five million people each year. Driven by a desire to cure Lisa of her own type 1 diabetes (T1D), the filmmakers were given unprecedented, real-time access to a clinical trial -- only the sixth-ever embryonic stem cell trial in the world. What follows is an intimate journey with the patients and scientists who risk everything to be first. More than a decade in the making, the first-person, verité film is about science, but it’s also an emotional, multilayered quest that transcends the genre. It’s about believing that the good of the many outweigh the good of the few. It’s about innovating in ways we didn’t think possible.
